Prostatic acid phosphatase levels (enzymatic method) from completely sectioned, clinically benign, whole prostates

Prostate

Volumn 28, Issue 5, 1996, Pages 295-299

  Brawn, P N ^a   Jay, D W ^b   Foster, D M ^e   Kuhl, D ^b   Speights, V O ^c   Johnson, E H ^b   Riggs, M ^c   Lind, M L ^f   Coffield, K S ^d   Weaver, B ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d TEXAS A M COLLEGE OF MEDICINE   (United States)

^e BAYLOR UNIVERSITY   (United States)

^f Kelsey Seybold Clinic   (United States)

Author keywords

acid phosphatase; atypical hyperplasia adenosis; prostate carcinoma; prostatic acid phosphatase; prostatic intraepithelial neoplasia

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME;

ACID PHOSPHATASE BLOOD LEVEL; ADULT; AGED; ARTICLE; CORRELATION FUNCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CARCINOMA;

ACID PHOSPHATASE; ADULT; AGED; AGED, 80 AND OVER; AUTOPSY; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; ORGAN SIZE; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATIC NEOPLASMS;

EID: 15844417382     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(199605)28:5<295::AID-PROS4>3.0.CO;2-B     Document Type: Article

References (14)

1. Brawn PN, Speights VO, Kuhl D, Riggs M, Spiekerman AM, McCord RG, Coffield KS, Stewart DT, Lind ML: Prostate-specific antigen levels from completely sectioned, clinically benign, whole prostates. Cancer 68: 1592-1599, 1991.
2. Brawn PN, Speights VO, Contin JU, Bayardo RJ, Kuhl DL: Atypical hyperplasia in prostates of 20-40 year old men. J Clin Pathol 42:383-386, 1989.
3. Helpap B: The biological significance of atypical hyperplasia of the prostate. Virchows Arch [A] 387:307-317, 1980.
4. McNeal JE: Normal histology of the prostate. Am J Surg Pathol 12:619-633, 1988.
5. Richie AW, Layfield LJ, Turcillo P, deKernion JB: The significance of atypia in fine needle aspiration cytology of the prostate. J Urol 140:761-765, 1988.
6. Brawn PN: Adenosis of the prostate: A dysplastic lesion that can be confused with prostate carcinoma. Cancer 49:826-833, 1982.
7. Gikas PW, Del Buono EA, Epstein JI: Florid hyperplasia of mesonephric remnants involving prostete and periprostatic tissue. Am J Surg Pathol 17:454-460, 1993.
8. Young RH, Clement PB: Sclerosing adenosis of the prostate. Arch Pathol Lab Med 111:363-366, 1987.
9. Ayala AG, Srigley JR, Ro JY, Abdul-Karim MFW, Johnson DE: Clear cell cribriform hyperplasia of the prostate. Am J Surg Pathol 10:665-671, 1986.
10. Bostwick DG, de la Roza G: Intraepithelial neoplasia: A call for standarized terminology. J Urol Pathol 1:95-103, 1993.
11. Panteghini M, Pagani F, Bonora R: Pre-analytical and biological variability of prostatic acid phosphatase and prostate specific antigen in serum from patients with prostate pathology. Eur J Clin Chem Clin Biochem 30: 135-139, 1992.
12. Foti AG, Herschman H, Cooper JF: Comparison of human prostatic acid phosphastase by measurement of enzymatic activity and by radioimmunoassay. Clin Chem 23:95-99, 1977.
13. Brawn PN, Foster DM, Jay DW, Kuhl D, Speights VO, Johnson EH, Coffield KS, Lind ML, Karl R, Weaver B: Characteristics of prostatic infarcts and their effect on serum prostate-specific antigen and prostatic acid phosphatase Urology 44:71-75, 1994.
14. Foti AG, Cooper JF, Herschman H, Malvaez RR: Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase. N Engl J Med 297:1357-1361, 1977.